Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Purified / Lyophilized / Biologically Active / Endotoxin Level: Less than 1.0 EU/µg protein.
INHBA / Inhibin Beta A
Met 1-Ser 424
HEK 293 Cells
Greater than 88% by SDS-PAGE
1. Measured by its binding ability in a functional ELISA. 2. Immobilized human ACVR2B at 10 µg/mL (100 µl/well) can bind biotinylated mouse INHBA-His, The EC50 of biotinylated mouse INHBA-His is 0.161 µg/mL. 2. Immobilized mouse INHBA-his at 10 µg/mL (100 µl/well) can bind human Follistatin Protein, The EC50 of human Follistatin Protein is 0.39 µg/mL.
Less than 1.0 EU/µg protein (determined by LAL method).
Lyophilized from sterile PBS, pH 7.4
Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
INHBA Protein, EDF Protein, Activin beta-A chain Protein, FSH-releasing protein Protein, Inhibin, beta A Protein, Inhibin beta A chain Protein, FRP Protein, Inhibin Beta A Protein, Inhibin, beta-1 Protein
The inhibin beta A subunit joins the alpha subunit to form a pituitary FSH secretion inhibitor. Inhibin has been shown to regulate gonadal stromal cell proliferation negatively and to have tumor-suppressor activity. In addition, serum levels of inhibin have been shown to reflect the size of granulosa-cell tumors and can therefore be used as a marker for primary as well as recurrent disease.